AI-generated summary
The authors report a randomized, double-blinded, placebo-controlled trial of photobiomodulation therapy in 20 male endurance athletes. They found 3000 m running was about 7 seconds faster with active treatment than placebo, with similar effort scores, and running economy improved by 5% 24 hours later. The authors also reported no change in perceived exertion or metabolic cost.
- Participants
- 20
- Who or what was studied
- Male endurance athletes (runners)
- Limits stated in the abstract
- The abstract reports a small sample of 20 male athletes and does not state the wavelengths or dosimetry used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.